Please activate JavaScript!
Please install Adobe Flash Player, click here for download

discovered_01_2013

discovered 01.13 FOCUS WWW.Hzdr.DE Within the Helmholtz Association, a strategic subsidiary of the caliber of an HZDR Innovation GmbH is practically unheard of. "It’s true we’re something of a model and, compared with other centers, we are right at the forefront with our spin-offs," says Kolitsch, not entirely without pride. He admits to owing a lot to the HZDR’s Technology Transfer and Legal Affairs unit. A common roof for other spin-offs HZDR Innovation GmbH has not sworn itself exclusively to ion beams but rather sees itself as a common roof for other spin-offs. The advantages inherent in this kind of holding are obvious: "Basically, you create your own in-house technology center, organize joint websites, appearances at conventions, marketing activities and - last but not least - help each other," explains Kolitsch. Adds Björn Wolf, head of the HZDR’s Technology Transfer and Legal Affairs unit: "If research findings give rise to new products, in other words, if it’s about revenue, Innovation GmbH comes into play." Already, there are a number of candidates: Take Gunter Gerbeth, for instance, with his patented ultrasound wave conductors, or Uwe Hampel with his grid sensors for measuring stream profiles, both of whom are drawing on HZDR Innovation GmbH. And the CEO himself is planning on launching a brand new product called i3membrane next year. Andreas Kolitsch lets us in on a little secret: "If we are successful at realizing this, it will be a hit." That’s all. For the second fiscal year, Kolitsch is counting on revenues in excess of one million Euros and on new medical technology projects. The company is currently in talks with manufacturers of artificial hip and knee joints and stents. Ion beams are supposed to help improve the tolerability and life of the "building components." So what’s next? "I’m guessing that 2017 will be an important year for us when we have to ask ourselves whether our goal is to become a globally unique center for ion implantations – in that case we need our own accelerators and beam lines - or do we just stop growing?" By the end of this year, Kolitsch plans to present a concept for his preferred option – growth. ContaCt _HZDR Innovation GmbH | Institute of Ion Beam Physics and Materials Research at HZDR Prof. Andreas Kolitsch a.kolitsch@hzdr.de andreas.kolitsch@hzdr-innovation.de _Technology Transfer & Legal Affairs at HZDR Dr. Björn Wolf b.wolf@hzdr.de www.hzdr-innovation.de In-house builders At the HZDR, Peter Kaever is head of research technology. With his team, he develops and realizes specialized research equipment for all eight of the HZDR’s institutes. This ranges from equipping individual experiments all the way to comprehensive research facilities like DRESDYN. Together with the scientists, the research technicians are frequently involved as early as the brainstorming stage. Later on, they’re in charge of construction and manufacturing, and finally, of on-site testing of the components. These days, the research technology department is especially involved in four major construction and development projects that are grouped under the umbrella term "future projects" at the HZDR. In all, the Free State of Saxony is funding these with over 70 million Euros; an additional 50 million are contributed by the Federal Ministry of Education and Research (BMBF). // At this point, it seems that DRESDYN is the one project at the HZDR that involves significant risk factors and thus deserves the full attention of Peter Kaever and Christian Steglich, head of the mechanical development division. // Another focus is on the expansion of ELBE. Neutron and positron based experimental stations are under construction at the new Center for High-Power Radiation Sources and the research technology department’s capacities are also tied up by the HZDR’s two high-power lasers, DRACO and PENELOPE. // The magnetic cells at the Dresden High Magnetic Field Laboratory’s add-on are still vacant. The job now is to equip them; the second capacitor bank’s switch towers are already open for tours. // A lesser workload for Kaever’s team is the Center for Radiopharmaceutical Tumor Research, which has to first experience additional building progress before the infrastructure for the transport of irradiated substances can be realized. www.hzdr.de/FWF

Pages